Carrie L. Bourdow
SVP, Chief Commercial Officer, Trevena Inc.
Companies
- Trevena IncBoard member Oct 1, 2018 to Oct 10, 20241
- Trevena IncChief executive officer Oct 1, 2018 to Oct 10, 20241
- Trevena IncPresident Oct 1, 2018 to Dec 15, 20231
- Nabriva Therapeutics plcBoard member Sep 19, 2017 to Aug 3, 20222
- Carisma Therapeutics Inc.Board member Feb 26, 2020 to Jun 24, 20223
- Trevena IncChief operating officer Mar 2, 2018 to Mar 2, 20184
- Trevena IncSVP, Chief Commercial Officer May 5, 2015 to Aug 29, 20175
- Nabriva Therapeutics plcDirector Aug 2, 2017 to Aug 2, 20176
- Nabriva Therapeutics (Austria)Board member Jun 27, 2017 to Jun 28, 20177
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Trevena Inc TRVN23,894 shares8$1.6K at $0.07Oct 8, 2024- Carisma Therapeutics Inc.40,000 shares9Jun 22, 2022
- Nabriva Therapeutics plc9,933 shares10Aug 1, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 8, 2024Shares withheld for tax 1,055 shares at $1.47 of Trevena Inc8
- Oct 8, 2024Shares withheld for tax 285 shares at $1.47 of Trevena Inc8
- Oct 8, 2024Shares withheld for tax 285 shares at $1.47 of Trevena Inc8
- Oct 8, 2024Shares withheld for tax 143 shares at $1.47 of Trevena Inc8
- Oct 8, 2024Shares withheld for tax 54 shares at $1.47 of Trevena Inc8
- Dec 14, 2023Shares withheld for tax 7,123 shares at $0.61 of Trevena Inc11
- Dec 14, 2023Granted 100,000 shares at $0.61 of Trevena Inc11
- Dec 14, 2023Granted 370,000 shares at $0.61 of Trevena Inc11
- Dec 2, 2023Shares withheld for tax 7,123 shares at $0.59 of Trevena Inc12
- Dec 2, 2023Shares withheld for tax 3,562 shares at $0.59 of Trevena Inc12
- Dec 2, 2023Shares withheld for tax 1,343 shares at $0.59 of Trevena Inc12
- Jan 6, 2023Granted 100,000 shares of Trevena Inc13
- Dec 17, 2022Shares withheld for tax 1,342 shares at $1.55 of Trevena Inc14
- Dec 2, 2022Shares withheld for tax 3,560 shares at $3.42 of Trevena Inc15
- Aug 1, 2022Sold 8,540 shares at $0.17 of Nabriva Therapeutics plc10
- Jun 22, 2022Granted 40,000 shares of Carisma Therapeutics Inc.9
- Dec 17, 2021Shares withheld for tax 33,546 shares at $0.70 of Trevena Inc16
- Dec 6, 2021Shares withheld for tax 93,561 shares at $0.65 of Trevena Inc17
- Dec 2, 2021Granted 1,250,000 shares of Trevena Inc18
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARTrevena Inc, Board member
- 2
- 3
- 4SEC EDGARTrevena Inc, Chief operating officer
- 5
- 6SEC EDGARNabriva Therapeutics plc, Director
- 7
- 8
- 9
- 10
- 11SEC EDGARForm 4 filed Dec 15, 2023
- 12SEC EDGARForm 4 filed Dec 5, 2023
- 13SEC EDGARForm 4 filed Jan 6, 2023
- 14SEC EDGARForm 4 filed Dec 20, 2022
- 15SEC EDGARForm 4 filed Dec 6, 2022
- 16SEC EDGARForm 4 filed Dec 21, 2021
- 17SEC EDGARForm 4 filed Dec 8, 2021
- 18SEC EDGARForm 4 filed Dec 3, 2021